NCT05963113

Brief Summary

The swallowing muscles are prone to decreased strength and function as part of the natural aging process which can lead to difficulty swallowing, malnutrition, and frailty. Exercise and nutrition are powerful stimulators of muscular change. The proposed research will investigate the effectiveness of a 12-week proactive regimen of swallowing exercises (with or without daily protein supplement drinks) to improve the composition, force, and physiology of the swallowing muscles and explore the relationship to overall health and physical function in 80 community-dwelling older adults. Each participant will serve as their own control for 12 weeks before being randomized to complete swallowing exercises alone or swallowing exercises with protein drinks.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
32mo left

Started May 2024

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress43%
May 2024Dec 2028

First Submitted

Initial submission to the registry

July 19, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 27, 2023

Completed
10 months until next milestone

Study Start

First participant enrolled

May 22, 2024

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2028

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Last Updated

August 5, 2025

Status Verified

August 1, 2025

Enrollment Period

4.3 years

First QC Date

July 19, 2023

Last Update Submit

August 4, 2025

Conditions

Keywords

proactive exerciseproteinnutrition

Outcome Measures

Primary Outcomes (8)

  • Change in Thickness of the Superior Pharyngeal Constrictor Muscle

    Axial T2-weighted images through the C1 level, hyoid bone and arytenoid cartilages will be used to measure the thickness of the superior pharyngeal constrictor muscle.

    Baseline, Week 13

  • Change in Thickness of the Superior Pharyngeal Constrictor Muscle

    Axial T2-weighted images through the C1 level, hyoid bone and arytenoid cartilages will be used to measure the thickness of the superior pharyngeal constrictor muscle.

    Baseline, Week 28

  • Change in Thickness of the Middle Pharyngeal Constrictor Muscle

    Axial T2-weighted images through the C1 level, hyoid bone and arytenoid cartilages will be used to measure the thickness of the middle pharyngeal constrictor muscle.

    Baseline, Week 13

  • Change in Thickness of the Middle Pharyngeal Constrictor Muscle

    Axial T2-weighted images through the C1 level, hyoid bone and arytenoid cartilages will be used to measure the thickness of the middle pharyngeal constrictor muscle.

    Baseline, Week 28

  • Change in Thickness of the Inferior Pharyngeal Constrictor Muscle

    Axial T2-weighted images through the C1 level, hyoid bone and arytenoid cartilages will be used to measure the thickness of the inferior pharyngeal constrictor muscle.

    Baseline, Week 13

  • Change in Thickness of the Inferior Pharyngeal Constrictor Muscle

    Axial T2-weighted images through the C1 level, hyoid bone and arytenoid cartilages will be used to measure the thickness of the inferior pharyngeal constrictor muscle.

    Baseline, Week 28

  • Change in Maximum Pharyngeal Constriction During Swallowing

    Maximum pharyngeal constriction area (normalized to spine length) will be captured at the height of the swallow on videofluoroscopy.

    Baseline, Week 13

  • Change in Maximum Pharyngeal Constriction During Swallowing

    Maximum pharyngeal constriction area (normalized to spine length) will be captured at the height of the swallow on videofluoroscopy.

    Baseline, Week 28

Secondary Outcomes (6)

  • Change in Short Physical Performance Battery (SPPB) Scores

    Baseline, Week 13

  • Change in Short Physical Performance Battery (SPPB) Scores

    Baseline, Week 28

  • Change in Fat-Free Muscle Index

    Baseline, Week 13

  • Change in Fat-Free Muscle Index

    Baseline, Week 28

  • Change in Pre-Albumin Levels

    Baseline, Week 13

  • +1 more secondary outcomes

Study Arms (2)

Control, then Swallowing Exercises + Protein

EXPERIMENTAL

Participants randomized to 12 weeks of swallowing exercises with protein supplementation, after completing an initial 12-week period of "usual activity."

Behavioral: Pharyngeal Swallowing ExercisesDietary Supplement: Protein SupplementationDevice: MRI

Control, then Swallowing Exercises

ACTIVE COMPARATOR

Participants randomized to 12 weeks of swallowing exercises without protein supplementation, after completing an initial 12-week period of "usual activity."

Behavioral: Pharyngeal Swallowing ExercisesDevice: MRI

Interventions

12-weeks of proactive pharyngeal swallowing exercises conducted 5 times per week. The exercise program will include the following four exercises: effortful saliva swallows, tongue-hold swallows, effortful pitch glides and posterior lingual resistance. Each exercise set will include 10 repetitions of each exercise (40 reps per set). The number of sets will be gradually increased as tolerance builds.

Control, then Swallowing ExercisesControl, then Swallowing Exercises + Protein
Protein SupplementationDIETARY_SUPPLEMENT

12-week supply of the commercially-available Premier Protein Clear ® High Protein (20 grams of protein and 90 calories per 16.9 oz. drink). Participants will be asked to consume one drink per day for the 12-week intervention period.

Control, then Swallowing Exercises + Protein
MRIDEVICE

Participants will be scanned using a 3T MRI scanner and a 16-channel phased array neck coil.

Control, then Swallowing ExercisesControl, then Swallowing Exercises + Protein

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Participants must be 65 years of age or older.
  • Participants must score a 1 or 2 on the FRAIL scale OR a 4 or greater on the Strength, Assistance in Walking, Rise from a Chair, Climb Stairs and Falls (SARC-F) Questionnaire.
  • Participants must score 26 or greater on the Montreal Cognitive Assessment (MoCA).
  • Willingness to participate in the study procedures.

You may not qualify if:

  • Known structural or neurological causes of dysphagia.
  • Cannot consume high levels of protein (Chronic Kidney Disease Stage 3 or higher).
  • Contraindications to 3T whole body MRI scanners (e.g., pacemaker, cerebral aneurysm clip, cochlear implant, presence of shrapnel in strategic locations, metal in the eye, claustrophobia, or other problems).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

NYU Steinhardt School of Education

New York, New York, 10003, United States

RECRUITING

NYU Langone Health

New York, New York, 10017, United States

RECRUITING

Study Officials

  • Sonja Molfenter

    NYU Langone Health

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sonja Molfenter

CONTACT

Maria Travino Sampler

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The PI, outcome assessors, and individuals conducting data analyses will be blinded to randomization. The treating clinicians and participants will be aware of their study group given that they will be provided with either water or protein drinks.
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 19, 2023

First Posted

July 27, 2023

Study Start

May 22, 2024

Primary Completion (Estimated)

August 31, 2028

Study Completion (Estimated)

December 31, 2028

Last Updated

August 5, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will share

The de-identified participant data from the final research dataset used in the published manuscript will be shared upon reasonable request beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research provided the investigator who proposes to use the data executes a data use agreement with NYU Langone Health. Requests may be directed to: smm16@nyu.edu. The protocol and statistical analysis plan will be made available on Clinicaltrials.gov only as required by federal regulation or as a condition of awards and agreements supporting the research.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.
Access Criteria
The investigator who proposed to use the data will be granted access upon reasonable request. Requests should be directed to smm16@nyu.edu. To gain access, data requestors will need to sign a data access agreement.

Locations